Neoadjuvant Immunochemotherapy vs Chemoradiotherapy in ESCC

Clinical trial NCT07236320 · COMPLETED

Trial details

NCT number: NCT07236320
Sponsor: Yongtao Han
Status: COMPLETED
Phase: Not Applicable
Study type: INTERVENTIONAL

Esophageal Squamous Cell Carcinoma (ESCC)

Start date: 2018-03-01
Primary completion: 2022-03-31
Enrollment: 200

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.